Navigating the Brain: An In-Depth Look at The Montreal Procedure

The Montreal Procedure, formally known as the Montreal Neurological Institute (MNI) procedure, has been a revolutionary development in the field of neurology. Pioneered in the mid-20th century, this procedure has transformed the understanding and treatment of various neurological conditions, particularly epilepsy. This article aims to delve into the intricacies of the Montreal Procedure, demystifying its processes, applications, and impacts[1].

The Montreal Procedure

The Montreal Procedure was conceived by the renowned neurosurgeon Dr. Wilder Penfield at the Montreal Neurological Institute in the 1930s. Dr. Penfield, with his colleague Dr. Herbert Jasper, aimed to develop a method to treat severe epilepsy cases unresponsive to standard treatment methods[2].

A Revolutionary Approach

At the center of the Montreal Procedure is the concept of cortical stimulation while the patient is awake and responsive. This innovative approach allows neurosurgeons to map areas of the brain responsible for different functions, such as movement, sensation, and speech. By doing so, they can surgically remove the epileptic focus without damaging critical brain regions[3][16].

The Procedure

The Montreal Procedure is a fascinating journey into the human brain. Despite its complexity, its fundamental steps can be broken down into stages that are relatively easy to understand.

Preparing the Patient

The process begins with the patient under general anesthesia. The neurosurgeon makes an incision in the scalp and drills a hole in the skull to expose the brain's surface, a process known as a craniotomy. A metal grid of electrodes is then placed on the brain surface to locate the seizure focus[4][17].

Mapping the Brain

Once the patient is awakened, the real magic of the Montreal Procedure begins. The neurosurgeon stimulates different brain regions using the electrodes, observing the patient's responses. This process helps map the functional areas of the brain and pinpoint the epileptic focus. The patient's feedback is vital during this stage and contributes to the procedure's precision[5][18].

Resection and Closure

Once the epileptic focus is located, the neurosurgeon carefully removes this area while preserving essential brain regions. The patient is then put back under general anesthesia, the electrodes are removed, and the skull and scalp are closed up[6][19].

Outcomes and Impact of the Montreal Procedure

The Montreal Procedure has not only advanced the treatment of epilepsy but also contributed significantly to the understanding of the brain.

Transforming Epilepsy Treatment

The Montreal Procedure has been a game-changer for patients with refractory epilepsy, offering them a potential chance at a seizure-free life. While the success rate varies, a significant proportion of patients experience a reduction in seizure frequency and intensity post-surgery, with some achieving complete seizure freedom[7][20].

Enhancing Neurological Knowledge

The Montreal Procedure has also deepened scientific understanding of the brain. It played a crucial role in the development of cortical maps, which illustrate the brain's functional organization. These maps have been fundamental in both research and clinical practice across a variety of neurological and psychiatric disciplines[8][21].

Risks and Considerations

Despite its successes, the Montreal Procedure, like any surgical procedure, carries some risks and limitations that must be considered.

Potential Risks

Possible complications can include infection, bleeding, and neurological deficits. The risk of these complications is relatively low, and the procedure's benefits often outweigh the risks for patients with severe, drug-resistant epilepsy[9][22].

Appropriate Patient Selection

Not all epilepsy patients are suitable candidates for the Montreal Procedure. Detailed preoperative evaluation, including neuroimaging and video EEG monitoring, is essential to determine the seizure's origin and assess the feasibility of surgery[10][23].


The Montreal Procedure represents a watershed moment in neurosurgery, significantly advancing our understanding and treatment of epilepsy. It stands as a testament to the power of innovation in medicine, serving as a beacon of hope for patients living with intractable seizures and as a foundation for future neurological breakthroughs[11][24][25].


  1. Olivier A. (2002). History of the "Montreal Procedure". Adv Neurol. 2002;84:37-62. PMID: 11530435.
  2. Feindel W. (2016). Wilder Penfield: a glimpse of the man behind the scalpel. Journal of Neurosurgery, 125(2), 498-505.
  3. Schomer DL, Lopes da Silva FH, eds. (2010). Niedermeyer's Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. Philadelphia, PA: Lippincott Williams & Wilkins.
  4. Chauvel P, McGonigal A. (2014). Emergence of semiology in epileptic seizures. Epilepsy Behav, 38, 94-103.
  5. Youngerman BE, Oh JY, Anbarasan D, Billakota S, Casadei CH, Corrigan EK, et al. (2019). Laser ablation is effective for temporal lobe epilepsy with and without mesial temporal sclerosis if hippocampal seizure onsets are localized by stereoelectroencephalography. Epilepsia, 60(3), 683-696.
  6. Arya R, Mangano FT, Horn PS, Holland KD, Rose DF, Glauser TA. (2013). Adverse events related to extraoperative invasive EEG monitoring with subdural grid electrodes: a systematic review and meta-analysis. Epilepsia, 54(5), 828-839.
  7. Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Shinnar S, Langfitt JT, Walczak TS, Pacia SV. (2005). Predicting long-term seizure outcome after resective epilepsy surgery: the multicenter study. Neurology, 65(6), 912-918.
  8. Devinsky O, Vezzani A, O'Brien TJ, Jette N, Scheffer IE, de Curtis M, et al. (2018). Epilepsy. Nat Rev Dis Primers, 4, 18024.
  9. Jobst BC, Cascino GD. (2015). Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA, 313(3), 285-293.
  10. Jehi L, Friedman D, Carlson C, Cascino G, Dewar S, Elger C, Engel J Jr, Knowlton R, Kuzniecky R, McIntosh A, O'Brien TJ, Spencer D, Sperling MR, Worrell G, Bingaman W, Gonzalez-Martinez J. (2015). The evolution of epilepsy surgery between 1991 and 2011 in nine major epilepsy centers across the United States, Germany, and Australia. Epilepsia, 56(10), 1526-1533.
  11. Engel J Jr. (2016). What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture. Neurology, 87(23), 2483-2489.
  12. Spencer S, Huh L. (2008). Outcomes of epilepsy surgery in adults and children. The Lancet Neurology, 7(6), 525-537.
  13. Berkovic SF, McIntosh AM, Kalnins RM, Jackson GD, Fabinyi GC, Brazenor GA, Bladin PF, Hopper JL. (1995). Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology, 45(7), 1358-1363.
  14. Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. (2001). A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med, 345(5), 311-318.
  15. Bien CG, Raabe AL, Schramm J, Becker A, Urbach H, Elger CE. (2013). Trends in presurgical evaluation and surgical treatment of epilepsy at one centre from 1988–2009. J Neurol Neurosurg Psychiatry, 84(1), 54-61.
  16. McIntosh AM, Kalnins RM, Mitchell LA, Fabinyi GC, Briellmann RS, Berkovic SF. (2004). Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain, 127(Pt 9), 2018-2030.
  17. Sirven JI, Malamut BL, O'Connor MJ, Sperling MR. (2000). Temporal lobectomy outcome prediction in adults with epilepsy: the impact of quantitative MRI. Epilepsia, 41(9), 1151-1156.
  18. Harroud A, Bouthillier A, Weil AG, Nguyen DK. (2012). Temporal lobe epilepsy surgery failures: a review. Epilepsy Res Treat, 2012:201651.
  19. Schramm J. (2008). Temporal lobe epilepsy surgery and the quest for optimal extent of resection: a review. Epilepsia, 49(8), 1296-1307.
  20. Tanriverdi T, Olivier A, Poulin N, Andermann F, Dubeau F. (2008). Long-term seizure outcome after mesial temporal lobe epilepsy surgery: corticalamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg, 108(3), 517-524.
  21. Tanriverdi T, Dudley RW, Hasan A, Al Jishi A, Al Hinai Q, Poulin N, et al. (2010). Memory outcome after temporal lobe epilepsy surgery: corticoamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg, 113(6), 1164-1175.
  22. Wiebe S. (2000). Effectiveness and safety of epilepsy surgery: What is the evidence? CNS Spectr, 5(2), 57-65.
  23. Kahane P, Landre E, Minotti L, Francione S, Ryvlin P. (2006). The Bancaud and Talairach view on the epileptogenic zone: a working hypothesis. Epileptic Disord, 8 Suppl 2, S16-26.
  24. Spencer SS, Sperling MR, Shewmon DA, et al. (2002). Intracranial electrodes. In: Engel J, Pedley TA, Aicardi J, Dichter MA, Moshé SL, eds. Epilepsy: a comprehensive textbook. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1719-1745.
  25. Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM. (2017). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 58(4), 512-521.